000 | 01963 a2200529 4500 | ||
---|---|---|---|
005 | 20250518004407.0 | ||
264 | 0 | _c20190318 | |
008 | 201903s 0 0 eng d | ||
022 | _a1950-6007 | ||
024 | 7 |
_a10.1016/j.biopha.2018.10.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRodrigues, Klinger Antonio da Franca | |
245 | 0 | 0 |
_aSB-83, a 2-Amino-thiophene derivative orally bioavailable candidate for the leishmaniasis treatment. _h[electronic resource] |
260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cDec 2018 |
||
300 |
_a1670-1678 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiprotozoal Agents _xadministration & dosage |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
650 | 0 | 4 |
_aInterleukin-10 _xmetabolism |
650 | 0 | 4 |
_aLeishmania _xdrug effects |
650 | 0 | 4 |
_aLeishmaniasis _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMutagens _xtoxicity |
650 | 0 | 4 | _aParasite Load |
650 | 0 | 4 |
_aParasites _xdrug effects |
650 | 0 | 4 |
_aThiophenes _xadministration & dosage |
650 | 0 | 4 | _aToxicity Tests, Acute |
700 | 1 | _aSilva, Daiana Karla Frade | |
700 | 1 | _aSerafim, Vanessa de Lima | |
700 | 1 | _aAndrade, Patrícia Néris | |
700 | 1 | _aAlves, Adriano Francisco | |
700 | 1 | _aTafuri, Wagner Luis | |
700 | 1 | _aBatista, Tatianne Mota | |
700 | 1 | _aMangueira, Vivianne Mendes | |
700 | 1 | _aSobral, Marianna Vieira | |
700 | 1 | _aMoura, Ricardo Olímpio de | |
700 | 1 | _aMendonça Junior, Francisco Jaime Bezerra | |
700 | 1 | _aOliveira, Márcia Rosa de | |
773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 108 _gp. 1670-1678 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2018.10.012 _zAvailable from publisher's website |
999 |
_c28989732 _d28989732 |